Outcome of COVID-19 Patients Presented with Gastrointestinal and Hepatic Manifestations

Table 5

Association between hospital outcomes and patients with abnormal liver chemistries at admission.

Hospital outcomes	Patients with normal; liver chemistry ()	Patients with abnormal; liver chemistry ()	Overall; ()	value
Hospital stay- days ()				0.148
HDU stay- days ()				<0.001
Mortality: expiry - %	4 (3.5%)	27 (21.3%)	31 (12.9%)	<0.001

Data are expressed as mean (SD) or (%). HDU: high-dependency units; SD: standard deviation.